NDMA Cautions Against Vaginal Antifungal Labels Implying 7-Day Superiority
This article was originally published in The Tan Sheet
Executive Summary
OTC vaginal antifungal labeling indicating seven-day treatments are more effective than the one- or three-day regimens should be avoided, Nonprescription Drug Manufacturers Association Senior VP and Director of Science & Technology William Soller, PhD, told FDA's Nonprescription Drugs Advisory Committee at a Sept. 11 meeting.